Significant developments include Obamacare price increases becoming public and the FDA's moves to speed up approvals for cheaper copycat drugs, both impacting healthcare affordability.

• Obamacare Prices Become Public, Highlighting Big Increases — The New York Times Health -
• F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs — The New York Times Health -